Back
Vontier Corp. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
48
VNT
Vontier Corp.
Last Price:
$37.81
Seasonality Move:
4.88%
Sell
39
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$34.13
Seasonality Move:
6.21%
Sell
48
Vontier Corp. (VNT)
is a Sell
Is Vontier Corp. a Buy, Sell or Hold?
-
The current Vontier Corp. [VNT] share price is $37.67. The Score for VNT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VNT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $34.34. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VNT Stock Price Chart
What is Vontier Corp.'s stock price today?
-
The Vontier Corp. share price today is $37.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $34.34The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
VNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.08 | Buy |
| Relative Strength Index (14 RSI): | 57.97 | Buy |
| Chaikin Money Flow: | 855627 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.03 - 36.91) | Buy |
| Bollinger Bands (100): | (37.25 - 43.03) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 48.76 | Sell |
| Chaikin Money Flow: | -1295237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Buy |
| Bollinger Bands (100): | (28.94 - 34.1) | Buy |
VNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.67 | Buy |
| 20-day SMA: | 35.89 | Buy |
| 50-day SMA: | 38.11 | Sell |
| 200-day SMA: | 37.44 | Buy |
| 8-day EMA: | 36.78 | Buy |
| 20-day EMA: | 33.37 | Buy |
| 50-day EMA: | 22.82 | Buy |
| 200-day EMA: | 7.96 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.02 | Sell |
| 20-day SMA: | 34.61 | Sell |
| 50-day SMA: | 33.59 | Buy |
| 200-day SMA: | 33.68 | Buy |
| 8-day EMA: | 35.6 | Sell |
| 20-day EMA: | 34.92 | Sell |
| 50-day EMA: | 33.67 | Buy |
| 200-day EMA: | 34.81 | Sell |
Vontier Corp. Earnings Growth & VNT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.23 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Vontier Corp. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||